-
Humans prefer interacting with slow, less realistic butterfly simulations
Authors:
Paige L. Reiter,
Talia Y. Moore
Abstract:
How should zoomorphic, or bio-inspired, robots indicate to humans that interactions will be safe and fun? Here, a survey is used to measure how human willingness to interact with a simulated butterfly robot is affected by different flight patterns. Flap** frequency, flap to glide ratio, and flap** pattern were independently varied based on a literature review of butterfly and moth flight. Huma…
▽ More
How should zoomorphic, or bio-inspired, robots indicate to humans that interactions will be safe and fun? Here, a survey is used to measure how human willingness to interact with a simulated butterfly robot is affected by different flight patterns. Flap** frequency, flap to glide ratio, and flap** pattern were independently varied based on a literature review of butterfly and moth flight. Human willingness to interact with these simulations and demographic information were self-reported via an online survey. Low flap** frequency and greater proportion of gliding were preferred, and prior experience with butterflies strongly predicted greater interaction willingness. The preferred flight parameters correspond to migrating butterfly flight patterns that are rarely directly observed by humans and do not correspond to the species that inspired the wing shape of the robot model. The most realistic butterfly simulations were among the least preferred. An analysis of animated butterflies in popular media revealed a convergence on slower, less realistic flight parameters. This iterative and interactive artistic process provides a model for determining human preferences and identifying functional requirements of robots for human interaction. Thus, the robotic design process can be streamlined by leveraging animated models and surveys prior to construction.
△ Less
Submitted 25 April, 2024;
originally announced April 2024.
-
Structural build-up at rest in the induction and acceleration periods of OPC
Authors:
Luca Michel,
Lex Reiter,
Antoine Sanner,
Robert J. Flatt,
David S. Kammer
Abstract:
Structural build-up in fresh cement paste at rest is characterized by time evolutions of storage modulus and yield stress, which both increase linearly in time during the induction period of hydration, followed by an exponential evolution after entering the acceleration period. While it is understood that C-S-H formation at contact points between cement particles dictates build-up in the accelerat…
▽ More
Structural build-up in fresh cement paste at rest is characterized by time evolutions of storage modulus and yield stress, which both increase linearly in time during the induction period of hydration, followed by an exponential evolution after entering the acceleration period. While it is understood that C-S-H formation at contact points between cement particles dictates build-up in the acceleration period, the mechanism in the induction period lacks consensus. Here, we provide experimental evidence that, at least in absence of admixtures, structural build-up at rest originates in both periods from the same mechanism. We couple calorimetry and oscillatory shear measurements of OPC at different w/c ratios, capturing how the storage modulus evolves with changes in cumulative heat. We obtain an exponential relation between stiffness and heat, with the same exponent in both the induction and acceleration periods. This suggests that C-S-H formation dictates build-up at rest in both periods.
△ Less
Submitted 3 April, 2024;
originally announced April 2024.
-
Using routinely collected patient data to support clinical trials research in accountable care organizations
Authors:
Andrew J McMurry,
Richen Zhang,
Alex Foxman,
Lawrence Reiter,
Ronny Schnel,
DeLeys Brandman
Abstract:
Background: More than half (57%) of pharma clinical research spend is in support of clinical trials. One reason is that Electronic Health Record (EHR) systems and HIPAA privacy rules often limit how broadly patient information can be shared, resulting in laborious human efforts to manually collect, de-identify, and summarize patient information for use in clinical studies.
Purpose: Conduct feasi…
▽ More
Background: More than half (57%) of pharma clinical research spend is in support of clinical trials. One reason is that Electronic Health Record (EHR) systems and HIPAA privacy rules often limit how broadly patient information can be shared, resulting in laborious human efforts to manually collect, de-identify, and summarize patient information for use in clinical studies.
Purpose: Conduct feasibility study for a Rheumatoid Arthritis (RA) clinical trial in an Accountable Care Organization. Measure prevalence of RA and related conditions matching study criteria. Evaluate automation of patient de-identification and summarization to support patient cohort development for clinical studies.
Methods: Collect original clinical documentation directly from the provider EHR system and extract clinical concepts necessary for matching study criteria. Automatically de-identify Protected Health Information (PHI) protect patient privacy and promote sharing. Leverage existing physician expert knowledge sources to enable analysis of patient populations.
Results: Prevalence of RA was four percent (4%) in the study population (mean age 53 years, 52% female, 48% male). Clinical documentation for 3500 patient were extracted from three (3) EHR systems. Grouped diagnosis codes revealed high prevalence of diabetes and diseases of the circulatory system, as expected. De-identification accurately removed 99% of PHI identifiers with 99% sensitivity and 99% specificity.
Conclusions: Results suggest the approach can improve automation and accelerate planning and construction of new clinical studies in the ACO setting. De-identification accuracy was better than previously approved requirements defined by four (4) hospital Institutional Review Boards.
△ Less
Submitted 25 June, 2018;
originally announced July 2018.
